Dapsone Impurity 37 | CAS 69391-11-3 - Request Quote
Dapsone Impurity 37
| SZ CAT No: | SZ-D044046 |
| CAS No | 69391-11-3 |
| Mol.F. | C12H12N2O4S2 |
| Mol.Wt. |
312.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Hazard Statement:
Usage Note:
Dapsone Impurity 37 is chemically 1,2-Bis(4-aminophenyl)-1l6,2l6-disulfane-1,1,2,2-tetraone. Dapsone Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Dapsone Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dapsone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 69391-11-3
Purchase 69391-11-3
Order 69391-11-3
Enquire 69391-11-3
price of 69391-11-3
69391-11-3 Supplier
69391-11-3 Manufacturer
69391-11-3 Exporter
buy high quality Dapsone Impurity 37
Purchase Dapsone Impurity 37
Dapsone Impurity 37 suppliers
Dapsone Impurity 37 manufacturers
Dapsone Impurity 37 price
Order Dapsone Impurity 37
Enquire Dapsone Impurity 37
Dapsone Impurity 37 cost
Dapsone Impurity 37 Supplier
Dapsone Impurity 37 Distributor
Dapsone Impurity 37 for Method Validation
Dapsone Reference Standard
Dapsone Impurity 37 for ANDA Filing
Dapsone Impurity 37 for Forced Degradation Studies
Dapsone Impurity 37 Identification Standards
Dapsone Impurity 37 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.